These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32658388)

  • 21. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.
    Alcalay RN; Caccappolo E; Mejia-Santana H; Tang M-; Rosado L; Orbe Reilly M; Ruiz D; Ross B; Verbitsky M; Kisselev S; Louis E; Comella C; Colcher A; Jennings D; Nance M; Bressman S; Scott WK; Tanner C; Mickel S; Andrews H; Waters C; Fahn S; Cote L; Frucht S; Ford B; Rezak M; Novak K; Friedman JH; Pfeiffer R; Marsh L; Hiner B; Siderowf A; Payami H; Molho E; Factor S; Ottman R; Clark LN; Marder K
    Neurology; 2012 May; 78(18):1434-40. PubMed ID: 22442429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GBA-Associated Parkinson's Disease: Progression in a Deep Brain Stimulation Cohort.
    Lythe V; Athauda D; Foley J; Mencacci NE; Jahanshahi M; Cipolotti L; Hyam J; Zrinzo L; Hariz M; Hardy J; Limousin P; Foltynie T
    J Parkinsons Dis; 2017; 7(4):635-644. PubMed ID: 28777757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impulse control behavior in GBA-mutated parkinsonian patients.
    Amami P; De Santis T; Invernizzi F; Garavaglia B; Albanese A
    J Neurol Sci; 2021 Feb; 421():117291. PubMed ID: 33383316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocerebrosidase Mutations and Motor Reserve in Parkinson's Disease.
    Chung SJ; Lee PH; Sohn YH; Kim YJ
    J Parkinsons Dis; 2021; 11(4):1715-1724. PubMed ID: 34459414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
    Berge-Seidl V; Pihlstrøm L; Maple-Grødem J; Forsgren L; Linder J; Larsen JP; Tysnes OB; Toft M
    Neurosci Lett; 2017 Sep; 658():48-52. PubMed ID: 28830825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients.
    Alcalay RN; Wolf P; Chiang MSR; Helesicova K; Zhang XK; Merchant K; Hutten SJ; Scherzer C; Caspell-Garcia C; Blauwendraat C; Foroud T; Nudelman K; Gan-Or Z; Simuni T; Chahine LM; Levy O; Zheng D; Li G; Sardi SP;
    Ann Clin Transl Neurol; 2020 Oct; 7(10):1816-1830. PubMed ID: 32888397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive impairment in carriers of glucocerebrosidase gene mutation in Parkinson disease patients.
    Malec-Litwinowicz M; Rudzińska M; Szubiga M; Michalski M; Tomaszewski T; Szczudlik A
    Neurol Neurochir Pol; 2014; 48(4):258-61. PubMed ID: 25168325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical profiles of Parkinson's disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals.
    Wang C; Cai Y; Gu Z; Ma J; Zheng Z; Tang BS; Xu Y; Zhou Y; Feng T; Wang T; Chen SD; Chan P;
    Neurobiol Aging; 2014 Mar; 35(3):725.e1-6. PubMed ID: 24095219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinson's disease cohort.
    Graham OEE; Pitcher TL; Liau Y; Miller AL; Dalrymple-Alford JC; Anderson TJ; Kennedy MA
    Parkinsonism Relat Disord; 2020 Jan; 70():36-41. PubMed ID: 31809948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson's Disease Patients with GBA Mutations.
    Caminiti SP; Carli G; Avenali M; Blandini F; Perani D
    Mov Disord; 2022 Jan; 37(1):106-118. PubMed ID: 34596920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GBA-associated PD presents with nonmotor characteristics.
    Brockmann K; Srulijes K; Hauser AK; Schulte C; Csoti I; Gasser T; Berg D
    Neurology; 2011 Jul; 77(3):276-80. PubMed ID: 21734182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study.
    Szwedo AA; Dalen I; Pedersen KF; Camacho M; Bäckström D; Forsgren L; Tzoulis C; Winder-Rhodes S; Hudson G; Liu G; Scherzer CR; Lawson RA; Yarnall AJ; Williams-Gray CH; Macleod AD; Counsell CE; Tysnes OB; Alves G; Maple-Grødem J;
    Mov Disord; 2022 May; 37(5):1016-1027. PubMed ID: 35106798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations.
    Yahalom G; Greenbaum L; Israeli-Korn S; Fay-Karmon T; Livneh V; Ruskey JA; Roncière L; Alam A; Gan-Or Z; Hassin-Baer S
    Parkinsonism Relat Disord; 2019 May; 62():179-184. PubMed ID: 30573413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-Glucocerebrosidase activity in
    Huh YE; Chiang MSR; Locascio JJ; Liao Z; Liu G; Choudhury K; Kuras YI; Tuncali I; Videnovic A; Hunt AL; Schwarzschild MA; Hung AY; Herrington TM; Hayes MT; Hyman BT; Wills AM; Gomperts SN; Growdon JH; Sardi SP; Scherzer CR
    Neurology; 2020 Aug; 95(6):e685-e696. PubMed ID: 32540937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.
    Cilia R; Tunesi S; Marotta G; Cereda E; Siri C; Tesei S; Zecchinelli AL; Canesi M; Mariani CB; Meucci N; Sacilotto G; Zini M; Barichella M; Magnani C; Duga S; Asselta R; Soldà G; Seresini A; Seia M; Pezzoli G; Goldwurm S
    Ann Neurol; 2016 Nov; 80(5):662-673. PubMed ID: 27632223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GBA-Associated Parkinson's Disease and Other Synucleinopathies.
    Gan-Or Z; Liong C; Alcalay RN
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):44. PubMed ID: 29884970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.
    Moraitou M; Hadjigeorgiou G; Monopolis I; Dardiotis E; Bozi M; Vassilatis D; Vilageliu L; Grinberg D; Xiromerisiou G; Stefanis L; Michelakakis H
    Mol Genet Metab; 2011; 104(1-2):149-52. PubMed ID: 21745757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel p.L216I mutation in the glucocerebrosidase gene is associated with Parkinson's disease in Han Chinese patients.
    Jin H; Chen J; Li K; Zhang JR; Gu CC; Mao CJ; Yang YP; Wang F; Liu CF
    Neurosci Lett; 2018 May; 674():66-69. PubMed ID: 29530815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease.
    Oeda T; Umemura A; Mori Y; Tomita S; Kohsaka M; Park K; Inoue K; Fujimura H; Hasegawa H; Sugiyama H; Sawada H
    Neurobiol Aging; 2015 Dec; 36(12):3306-3313. PubMed ID: 26422360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical profiles associated with LRRK2 and GBA mutations in Brazilians with Parkinson's disease.
    da Silva CP; de M Abreu G; Cabello Acero PH; Campos M; Pereira JS; de A Ramos SR; Nascimento CM; Voigt DD; Rosso AL; Araujo Leite MA; Vasconcellos LFR; Nicaretta DH; Della Coletta MV; da Silva DJ; Gonçalves AP; Dos Santos JM; Calassara V; Valença DCT; de M Martins CJ; Santos-Rebouças CB; Pimentel MMG
    J Neurol Sci; 2017 Oct; 381():160-164. PubMed ID: 28991672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.